SeQuent Scientific and Viyash Lifesciences announce strategic merger

Sequent Scientific, a leading player in the animal health industry, has announced a strategic merger with Viyash Lifesciences. The merger is aimed at consolidating both companies' capabilities in veterinary pharmaceuticals, research, and development. By joining forces, the companies will be better positioned to capture a larger share of the global animal health market, which has been growing steadily due to increased pet ownership and the rising demand for livestock health products. The merger will also enable the companies to expand their product portfolio, enhance R&D capabilities, and strengthen their market presence, particularly in emerging markets. This strategic move reflects the broader trend of consolidation in the pharmaceutical industry.